Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,514.40
+0.9%
+70.15
Arrow-Thin-Down
DJI
50,159.38
+0.9%
+466.18
Arrow-Thin-Down
NASDAQ
26,694.41
+1.1%
+292.07
Arrow-Thin-Down
Bitcoin
$81,440.00
+3.3%
+$2,613.47
Arrow-Thin-Down
AAPL
$298.80
-0.0%
-$0.07
Arrow-Thin-Down
AMZN
$268.20
-0.7%
-$1.93
Arrow-Thin-Down
GOOG
$397.04
-0.5%
-$2.00
Arrow-Thin-Down
META
$623.07
+1.0%
+$6.44
Arrow-Thin-Down
MSFT
$408.02
+0.7%
+$2.81
Arrow-Thin-Down
NVDA
$235.59
+4.3%
+$9.76
Arrow-Thin-Down
TSLA
$451.54
+1.4%
+$6.27
Most Active StocksDaily Stock GainersDaily Stock Losers
Crinetics Pharmaceuticals logo

Crinetics Pharmaceuticals

(NASDAQ) CRNX

Current Price$37.42
Market Cap$3.95B
Since IPO (2018)+53%
5 Year+131%
1 Year+21%
1 Month-3%

Crinetics Pharmaceuticals Financials at a Glance

Market Cap

$3.95B

Revenue (TTM)

$18.07M

Net Income (TTM)

$496.39M

EPS (TTM)

$-5.13

P/E Ratio

-7.30

Dividend

$0.00

Beta (Volatility)

1.17 (Average)

Price

$37.42

Volume

7,544

Open

$38.00

Previous Close

$37.48

Daily Range

$36.78 - $38.00

52-Week Range

$25.83 - $57.99

CRNX News

SellAlert-Green.png

Crinetics Director Sells 5,000 Shares With Stock Down 4%, but Here's What Matters More

Jonathan PoncianoMar 27, 2026
SellAlert-Red.png

Biotech Fund Dumps $12.3 Million in Crinetics Stock as Shares Remain 19% Lower on the Year

Jonathan PoncianoNov 27, 2025
Healthcare professional inspecting charts

Why Crinetics Pharmaceuticals Stock Was Sliding on Friday

Eric VolkmanNov 7, 2025
biotech researcher

Is Crinetics Pharmaceuticals Stock a Buy?

George Budwell, PhDSep 28, 2025
Foolcom-Featured.png

Crinetics (CRNX) Q2 Revenue Jumps 150%

Motley Fool Markets TeamAug 7, 2025
two scientists work at lab bench with scope

Up 83% in 5 Days, Is Crinetics Pharmaceuticals a Buy?

Alex CarchidiSep 19, 2023
growth curve

Why Crinetics Pharmaceuticals Stock Soared This Week

George Budwell, PhDSep 15, 2023
pharmacy pharmacist drug medicine prescription (2)

Why Shares of Crinetics Pharmaceuticals Are Jumping Monday

James HalleySep 11, 2023
Page 1

CRNX: Motley Fool Moneyball Superscore

67

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Crinetics Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

594

CEO

Scott R. Struthers, PhD

Website

www.crinetics.com

Headquarters

San Diego, CA 92121, US

CRNX Financials

Key Financial Metrics (TTM)

Gross Margin

99%

Operating Margin

-30%

Net Income Margin

-27%

Return on Equity

-39%

Return on Capital

-41%

Return on Assets

-35%

Earnings Yield

-13.70%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.95B

Shares Outstanding

105.44M

Volume

7.54K

Avg. Volume

1.20M

Financials (TTM)

Gross Profit

$6.62M

Operating Income

$516.77M

EBITDA

$512.88M

Operating Cash Flow

$377.92M

Capital Expenditure

$5.76M

Free Cash Flow

$383.68M

Cash & ST Invst.

$1.03B

Total Debt

$48.54M

Crinetics Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$10.73M

+2873.4%

Gross Profit

$10.53M

+2818.0%

Gross Margin

98.14%

N/A

Market Cap

$3.95B

N/A

Market Cap/Employee

$9.04M

N/A

Employees

437

N/A

Net Income

$127.84M

-32.1%

EBITDA

$139.22M

-26.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$1.24B

+1.6%

Accounts Receivable

$5.68M

-22.3%

Inventory

$3.06M

N/A

Long Term Debt

$41.32M

-6.0%

Short Term Debt

$6.54M

-5.0%

Return on Assets

-35.42%

N/A

Return on Invested Capital

-41.03%

N/A

Free Cash Flow

$125.52M

-40.0%

Operating Cash Flow

$124.70M

-41.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ACADACADIA Pharmaceuticals Inc.
$22.24+0.27%
VKTXViking Therapeutics, Inc.
$31.46-0.76%
NAMSNewAmsterdam Pharma Company N.V.
$37.35-1.07%
XENEXenon Pharmaceuticals Inc.
$55.46-0.75%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$14.66-0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$17.22+0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$79.58+0.03%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.76-0.03%

Questions About CRNX

What is the current price of Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals is trading at $37.42 per share.

What is the 52-week range for Crinetics Pharmaceuticals?

Over the past 52 weeks, Crinetics Pharmaceuticals has traded between $25.83 and $57.99.

How much debt does Crinetics Pharmaceuticals have?

As of the most recent reporting period, Crinetics Pharmaceuticals reported total debt of $47.85M.

How much cash does Crinetics Pharmaceuticals have on hand?

Crinetics Pharmaceuticals reported $114.34M in cash and cash equivalents in its most recent financial results.

What is Crinetics Pharmaceuticals’s dividend yield?

Crinetics Pharmaceuticals does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services